With its significant cash infusions from offloading its COVID assets, Novavax had just over $1 billion as it exited Q3, 2024.

Investing.com -- The U.S. Food and Drug Administration (FDA) has lifted its hold on a late-stage trial for Novavax’s COVID-influenza combination and standalone flu vaccines, the company reported ...

At-home COVID-19 tests were an important part of preventing viral spread during the pandemic, and now there are FDA-approved tests ... authorization for a combo flu and COVID-19 test to the ...

Recently, the possibility of a 'multi-demic' is increasing as various respiratory infections, including influenza (flu ... vaccine that simultaneously prevents COVID-19, influenza, and RSV ...

Since then, the COVID vaccine has been credited with saving millions of lives and alleviating the burden on hospitals that became overwhelmed in the early days of the pandemic. The FDA denied the ...

The Food and Drug Administration (FDA) will begin collecting samples of raw cow’s milk cheese from across the U.S. to test for the presence of bird flu, spurred on by the ongoing outbreaks of ...

Novavax shares are trading lower by 9.8% during Monday's session. Shares of vaccine stocks are trading lower after Moderna ...

The Food and Drug Administration has determined that it is necessary for manufacturers of cat and dog foods who are covered by the FDA Food Safety Modernization Act Preventive Controls for Animal ...

Along with flu, winter months are highs for the common cold, RSV and COVID-19. Here's what to know ... mouth or eyes. The flu vaccine, for everyone ages 6 months and older, is crucial, Dr. Eduardo ...

and 92.5% and 90.5% of positive Flu A and Flu B samples, the FDA said. It didn't specify in the news release which strain of COVID was circulating at the time the study was conducted.